Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased <i>in vitro</i> activity: a nationwide real-world multicenter cohort study.

Front Cell Infect Microbiol · 2023 · PMC10225538 · PMID 37256107

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rate of O2 supplementation with facial mask was significantly lower in regdanvimab despite difference of composite outcome did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.